Search Results - Xiu, Dianrong, Prof

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study

    Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Bai, Chunmei, Prof, Wang, Wei, MD, Li, Jie, Prof, Yu, Xianjun, Prof, Li, Zhiping, Prof, Li, Enxiao, Prof, Yuan, Xianglin, Prof, Chi, Yihebali, Prof, Yin, Yongmei, Prof, Lou, Wenhui, Prof, Xu, Nong, Prof, Bai, Yuxian, Prof, Zhang, Tao, Prof, Xiu, Dianrong, Prof, Wang, Xiuwen, Prof, Yuan, Ying, Prof, Chen, Jia, Prof, Qin, Shukui, Prof, Jia, Ru, MD, Lu, Ming, MD, Cheng, Yuejuan, MD, Zhou, Zhiwei, Prof, Li, Jing, MD, He, James, MD, Su, Weiguo, PhD

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study

    Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Zhou, Zhiwei, Prof, Li, Jie, Prof, Bai, Chunmei, Prof, Chi, Yihebali, Prof, Li, Zhiping, Prof, Xu, Nong, Prof, Li, Enxiao, Prof, Liu, Tianshu, Prof, Bai, Yuxian, Prof, Yuan, Ying, Prof, Li, Xingya, Prof, Wang, Xiuwen, Prof, Chen, Jia, Prof, Ying, Jieer, Prof, Yu, Xianjun, Prof, Qin, Shukui, Prof, Yuan, Xianglin, Prof, Zhang, Tao, Prof, Deng, Yanhong, Prof, Xiu, Dianrong, Prof, Cheng, Ying, Prof, Tao, Min, Prof, Jia, Ru, MD, Wang, Wei, MD, Li, Jing, MD, Fan, Songhua, MD, Peng, Mengye, PhD, Su, Weiguo, PhD

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: